PROCTER & GAMBLE HEALTH
|
The Current P/B Ratio of PROCTER & GAMBLE HEALTH is 18.27.
Share Price | ₹5,830.0 | Jul 24,2025 |
Market Cap | ₹9,677.7 Cr | |
Book Value | ₹529.7 Cr | Jun2024 - Standalone Results |
Price/Book | 18.27x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of PROCTER & GAMBLE HEALTH
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹9,677.7 Cr] as on Jul 24,2025
(/) Book Value [ ₹529.7 Cr] based on Jun2024 - Standalone Results
(=) P/B Ratio [ 18.27x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '18.27 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/B Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PB (Price/Book ) ratio chart of PROCTER & GAMBLE HEALTH
PB Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/b ratio for fiscal years ending Jun2024 to Jun2020 averaged 11.94x.
- PROCTER & GAMBLE HEALTH 's operated at median p/b ratio of 11.73x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/b ratio peaked in Jun2024 at 15.83x.
- PROCTER & GAMBLE HEALTH 's p/b ratio hit its five-year low in Jun2020 of 7.47x.
How does PROCTER & GAMBLE HEALTH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
PROCTER & GAMBLE HEALTH | 529.71 | 18.27 | 9,677.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.62 | 405,991.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 11.74 | 175,720.0 |
CIPLA LTD | 31,079.30 | 3.87 | 120,133.0 |
TORRENT PHARMACEUTICALS LTD | 7,590.69 | 15.68 | 118,994.0 |
DR REDDYS LABORATORIES LTD | 33,404.90 | 3.16 | 105,562.0 |
MANKIND PHARMA LTD | 14,288.70 | 7.47 | 106,806.0 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.08 | 97,710.4 |
LUPIN LTD | 17,119.50 | 5.18 | 88,764.3 |
AUROBINDO PHARMA LTD | 32,653.30 | 1.98 | 64,663.6 |
ABBOTT INDIA LTD | 4,204.27 | 17.51 | 73,597.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PROCTER & GAMBLE HEALTH 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 1.98x |
Max industry PB | 18.27x |
Median industry PB | 5.62x |
Average industry PB | 8.60x |
You may also like the below Video Courses